Lanterna Rally
eBook PDF Download Digital Library
Brand Name Prescription Drug Antitrust Litigation Survey
In Re: Ciprofloxacin Hydrochloride Antitrust Litigation
Author:
Publisher:
Published: 2008
Total Pages: 40
ISBN-13:
DOWNLOAD EBOOK →The plaintiffs in In re: Ciprofloxacin hydrochloride (Cipro) Antitrust Litigation (consumers and advocacy groups), sued the the brand name antibiotic's manufacturer Bayer, and prospective manufacturers of cheaper generic version, claiming that the exclusion agreement under which proposed manufacturers agreed to defer entry into market until expiration of patent held by Bayer, in return for payments to be received from Bayer, was in violation of antitrust laws. This amicus brief supports the plaintiffs, arguing in part that the case should have been decided in federal circuit court and that exclusion payments are generally anticompetitive.
In Re: Tamoxifen-citrate Antitrust Litigation
Author:
Publisher:
Published: 2005
Total Pages: 42
ISBN-13:
DOWNLOAD EBOOK →The plaintiffs in In re: Taxmoxifen Citrate Antitrust Litigation (who include pharmaceutical consumers, third party payors, and a health care advocacy group) filed a Petition for Writ of Certiorari asking the Supreme Court to review the Second Circuit's decision affirming the dismissal of this antitrust case. The plaintiffs alleged antitrust violations based on a $21 million payment from AstraZeneca (the tamoxifen NDA holder) to Barr Labs (the ANDA filer) in exchange for Barr's promise to withdraw its Paragraph IV certification and abandon its challenge of the tamoxifen patent.
Paying off generics to prevent competition with brand name drugs : should it be prohibited? : hearing
Author:
Publisher: DIANE Publishing
Published:
Total Pages: 186
ISBN-13: 9781422322987
DOWNLOAD EBOOK →In Re: Tamoxifen-citrate Antitrust Litigation
Author:
Publisher:
Published: 2005
Total Pages: 44
ISBN-13:
DOWNLOAD EBOOK →The case concerns a decision by a divided panel of the Appeals Court upholding the dismissal of an antitrust challenge to a patent litigation settlement between AstraZeneca, the manufacturer of tamoxifen citrate, the most widely prescribed drug for breast cancer treatment, and Barr Labs., a U.S. Food and Drug Administration applicant for a generic counterpart.
In Re Brand Name Prescription Drugs Antitrust Litigation
Blackburn V. Sweeney
How Increased Competition from Generic Drugs Has Affected Prices and Returns in the Pharmaceutical Industry
Author:
Publisher: U.S. Government Printing Office
Published: 1998
Total Pages: 94
ISBN-13:
DOWNLOAD EBOOK →Generic drug entry prior to patent expiration an FTC study
Author:
Publisher: DIANE Publishing
Published: 2002
Total Pages: 129
ISBN-13: 1428951938
DOWNLOAD EBOOK →